Frontiers in medicine

[1] Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes.

[2] soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1

[3] regulation of nuclear factor-κb in intestinal epithelial cells in a cell model of inflammation

[4] EI-2346, a novel interleukin-1beta converting enzyme inhibitor produced by Streptomyces sp. E-2346. I. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.

[5] EI-1941-1 and -2, novel interleukin-1 beta converting enzyme inhibitors Produced by Farrowia sp. E-1941. II. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.

[6] Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages.

[7] [Association between interleukin-17A and 17F single nucleotide polymorphisms and knee osteoarthritis].

[8] Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma

[9] Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma

[10] Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression

[11] Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze

[12] Effect of scaling and root planing on serum interleukin-10 levels and glycemic control in chronic periodontitis and type 2 diabetes mellitus

[13] Evaluation of levels of Interleukin-1b, intensity of pain and tooth movement during canine retraction using different magnitudes of continuous orthodontic force.

[14] Interferon-γ and interleukin-12 production in relation to gene polymorphisms in BCG osteitis.

[15] Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives

[16] 14BME20 Prevents Allergic Airway Inflammation by Induction of Regulatory T Cells via Interleukin-10.

[17] Interleukin-18 expression in pig salivary glands and salivary content changes during acute immobilization stress

[18] [Association of interleukin-10 gene polymorphism with enterovirus 71 infection in children].

[19] Adenine decreases hypertrophic effects through interleukin-18 receptor.

[20] CD36 Shunts Eicosanoid Metabolism to Repress CD14 Licensed Interleukin-1β Release and Inflammation.

[21] Lack of Association between Interleukin-18 –607 C/A Gene Polymorphism and Pulmonary Tuberculosis in Zahedan, Southeast Iran

[22] Involvement of Interleukin-10 in Analgesia of Electroacupuncture on Incision Pain.

[23] Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

[24] miR-330 regulates interleukin-13-induced MUC5AC secretion by targeting Munc18b in human bronchial epithelial cells.

[25] Gingival crevicular fluid levels of interleukin-18 and tumor necrosis factor-alpha in type 1 diabetic children with gingivitis.

[26] Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis

[27] Interleukin-18 from neurons and microglia mediates depressive behaviors in mice with post-stroke depression.

[28] Correction to: Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

[29] Determinants of Response to Interleukin-10 Receptor Blockade Immunotherapy in Experimental Visceral Leishmaniasis

[30] Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis

[31] Koi Herpesvirus Encodes and Expresses a Functional Interleukin-10

[32] thromboxane a2 receptor stimulation enhances microglial interleukin-1β and no biosynthesis mediated by the activation of erk pathway

[33] interleukin-1β affects mdamb231 breast cancer cell migration under hypoxia: role of hif-1α and nfκb transcription factors

[34] overexpression of microrna-155 suppresses chemokine expression induced by interleukin-13 in beas-2b human bronchial epithelial cells

[35] effect of levodopa on interleukin-15 and rantes circulating levels in patients affected by parkinson's disease

[36] analysis of association between different hcv genotypes and serum interleukin-17, interleukin-6, and vitamin d in patients with hcv-related cirrhosis

[37] impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia

[38] potential use of interleukin-10 blockade as a therapeutic strategy in human cutaneous leishmaniasis

[39] serum interleukin-6, interleukin-17a, and transforming growth factor beta are raised in systemic sclerosis with interstitial lung disease

[40] interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis

[41] lysosomal ca2+ signaling regulates high glucose-mediated interleukin-1β secretion via transcription factor eb in human monocytic cells

[42] polymorphisms in the interleukin-10 gene and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases

[43] effect of electroacupuncture at distal–proximal acupoint combinations on spinal interleukin-1 beta in a rat model of neuropathic pain

[44] association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression

[45] soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1

[46] cpg and interleukin-15 synergize to enhance ifn-γ production by activated cd8+ t cells

[47] bee venom acupuncture reduces interleukin-6, increases interleukin-10, and induces locomotor recovery in a model of spinal cord compression

[48] molecular characterization of the onset and progression of colitis in inoculated interleukin-10 gene-deficient mice: a role for pparα

[49] increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes’ mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication

[50] interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model

[51] polymorphism of interleukin-1β gene in children of chernivtsi region and its impact on development of duodenal ulcer

[52] significant roles played by interleukin-10 in outcome of pregnancy

[53] schistosoma mansoni antigen-driven interleukin-10 production in infected asthmatic individuals

[54] interleukin-1 receptor blockade in perinatal brain injury

[55] adaptive natural killer cells integrate interleukin-18 during target-cell encounter

[56] induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific t helper 2 responses

[57] Interleukin-18 Involvement in Hypoxic–Ischemic Brain Injury

[58] Hematopoietic activities of interleukin-1 alpha: in vitro and in vivo modulation by an anti-IL-1 receptor antibody

[59] Pulmonary Colonization Resistance to Pathogens via Noncanonical Wnt and Interleukin-17A by Intranasal pep27 Mutant Immunization

[60] A Dectin-1-Caspase-8 Pathway Licenses Canonical Caspase-1 Inflammasome Activation and Interleukin-1β Release in Response to a Pathogenic Fungus

[61] Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis

[62] USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA

[63] Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection

[64] Interleukin-1β Induces Tissue Factor Expression in A549 Cells via EGFR-Dependent and -Independent Mechanisms